The activation of bystander CD8+ T cells and their roles in viral infection
During viral infections, significant numbers of T cells are activated in a T cell receptor-
independent and cytokine-dependent manner, a phenomenon referred to as “bystander …
independent and cytokine-dependent manner, a phenomenon referred to as “bystander …
[HTML][HTML] The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
X Chen, Y Zhang, Y Fu - Medicine in Drug Discovery, 2022 - Elsevier
Toll-like receptors (TLR) play a dual regulatory role in the tumor microenvironment (TME).
TLR agonists (TLRa) elicit both innate and adaptive immune responses to achieve anti …
TLR agonists (TLRa) elicit both innate and adaptive immune responses to achieve anti …
[HTML][HTML] Advances in targeting the innate and adaptive immune systems to cure chronic hepatitis B virus infection
Z Meng, Y Chen, M Lu - Frontiers in Immunology, 2020 - frontiersin.org
“Functional cure” is being pursued as the ultimate endpoint of antiviral treatment in chronic
hepatitis B (CHB), which is characterized by loss of HBsAg whether or not anti-HBs …
hepatitis B (CHB), which is characterized by loss of HBsAg whether or not anti-HBs …
[HTML][HTML] T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells
Y Nouri, R Weinkove, R Perret - Journal for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Toll-like receptors (TLRs) are evolutionarily conserved molecules that specifically recognize
common microbial patterns, and have a critical role in innate and adaptive immunity …
common microbial patterns, and have a critical role in innate and adaptive immunity …
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy
Our bodies are inhabited by trillions of microorganisms. The host immune system constantly
interacts with the microbiota in barrier organs, including the intestines. Over decades …
interacts with the microbiota in barrier organs, including the intestines. Over decades …
Toll-like receptor 7 activation enhances CD8+ T cell effector functions by promoting cellular glycolysis
The activation of TLR7 signaling in T cells accelerates antigen-specific responses. Such
responses play an essential role in eliminating viral infections and can be anti-tumorigenic …
responses play an essential role in eliminating viral infections and can be anti-tumorigenic …
Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response
L Roßmann, K Bagola, T Stephen… - Proceedings of the …, 2021 - National Acad Sciences
The COVID-19 pandemic highlights the importance of efficient and safe vaccine
development. Vaccine adjuvants are essential to boost and tailor the immune response to …
development. Vaccine adjuvants are essential to boost and tailor the immune response to …
A comprehensive RNA editome reveals that edited Azin1 partners with DDX1 to enable hematopoietic stem cell differentiation
F Wang, J He, S Liu, A Gao, L Yang… - Blood, The Journal …, 2021 - ashpublications.org
Adenosine-to-inosine RNA editing and the catalyzing enzyme adenosine deaminase are
both essential for hematopoietic development and differentiation. However, the RNA …
both essential for hematopoietic development and differentiation. However, the RNA …
[HTML][HTML] CD8+ T Cell-mediated mechanisms contribute to the progression of neurocognitive impairment in both multiple sclerosis and Alzheimer's disease?
Z Stojić-Vukanić, S Hadžibegović, O Nicole… - Frontiers in …, 2020 - frontiersin.org
Neurocognitive impairment (NCI) is one of the most relevant clinical manifestations of
multiple sclerosis (MS). The profile of NCI and the structural and functional changes in the …
multiple sclerosis (MS). The profile of NCI and the structural and functional changes in the …
[HTML][HTML] The potential role of the intestinal micromilieu and individual microbes in the immunobiology of chimeric antigen receptor T-cell therapy
ML Schubert, R Rohrbach, M Schmitt… - Frontiers in …, 2021 - frontiersin.org
Cellular immunotherapy with chimeric antigen receptor (CAR)-T cells (CARTs) represents a
breakthrough in the treatment of hematologic malignancies. CARTs are genetically …
breakthrough in the treatment of hematologic malignancies. CARTs are genetically …